Absci (ABSI) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ABSI Absci Corp ABSI
46 GF Score
Price $8.47
GF Value $0.92
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Absci Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ABSI
46GF Score
Absci Corp ABSI
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Absci (ABSI) Overvalued in 2026?

Based on GuruFocus' analysis, Absci stock appears to be overvalued. The current stock price of $8.47 is trading 820.7% above its estimated GF Value™ of $0.92. GuruFocus considers Absci to be Significantly Overvalued.

Key valuation signals for ABSI:

  • Short Ratio:
  • GF Value™: $0.92 vs. price of $8.47 (820.7% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the ABSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Absci Business Description

Address 18105 SE Mill Plain Boulevard, Vancouver, WA, USA, 98683
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
46GF Score

Get the complete analysis for ABSI

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.47
Price
$0.92
GF Value